Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 33 entries
Sorted by: Best Match Show Resources per page
Corrigendum: Rare variants of large effect in BRCA2 and CHEK2 affect risk of lung cancer.

Nature genetics

Wang Y, McKay JD, Rafnar T, Wang Z, Timofeeva MN, Broderick P, Zong X, Laplana M, Wei Y, Han Y, Lloyd A, Delahaye-Sourdeix M, Chubb D, Gaborieau V, Wheeler W, Chatterjee N, Thorleifsson G, Sulem P, Liu G, Kaaks R, Henrion M, Kinnersley B, Vallée M, Le Calvez-Kelm F, Stevens VL, Gapstur SM, Chen WV, Zaridze D, Szeszenia-Dabrowska N, Lissowska J, Rudnai P, Fabianova E, Mates D, Bencko V, Foretova L, Janout V, Krokan HE, Gabrielsen ME, Skorpen F, Vatten L, Njølstad I, Chen C, Goodman G, Benhamou S, Vooder T, Välk K, Nelis M, Metspalu A, Lener M, Lubiński J, Johansson M, Vineis P, Agudo A, Clavel-Chapelon F, Bueno-de-Mesquita HB, Trichopoulos D, Khaw KT, Johansson M, Weiderpass E, Tjønneland A, Riboli E, Lathrop M, Scelo G, Albanes D, Caporaso NE, Ye Y, Gu J, Wu X, Spitz MR, Dienemann H, Rosenberger A, Su L, Matakidou A, Eisen T, Stefansson K, Risch A, Chanock SJ, Christiani DC, Hung RJ, Brennan P, Landi MT, Houlston RS, Amos CI.
PMID: 28358128
Nat Genet. 2017 Mar 30;49(4):651. doi: 10.1038/ng0417-651a.

No abstract available.

Cite
Wang Y, McKay JD, Rafnar T, et al. Corrigendum: Rare variants of large effect in BRCA2 and CHEK2 affect risk of lung cancer. Nat Genet. 2017;49(4):651doi: 10.1038/ng0417-651a.
Wang, Y., McKay, J. D., Rafnar, T., Wang, Z., Timofeeva, M. N., Broderick, P., Zong, X., Laplana, M., Wei, Y., Han, Y., Lloyd, A., Delahaye-Sourdeix, M., Chubb, D., Gaborieau, V., Wheeler, W., Chatterjee, N., Thorleifsson, G., Sulem, P., Liu, G., Kaaks, R., Henrion, M., Kinnersley, B., Vallée, M., Le Calvez-Kelm, F., Stevens, V. L., Gapstur, S. M., Chen, W. V., Zaridze, D., Szeszenia-Dabrowska, N., Lissowska, J., Rudnai, P., Fabianova, E., Mates, D., Bencko, V., Foretova, L., Janout, V., Krokan, H. E., Gabrielsen, M. E., Skorpen, F., Vatten, L., Njølstad, I., Chen, C., Goodman, G., Benhamou, S., Vooder, T., Välk, K., Nelis, M., Metspalu, A., Lener, M., Lubiński, J., Johansson, M., Vineis, P., Agudo, A., Clavel-Chapelon, F., Bueno-de-Mesquita, H. B., Trichopoulos, D., Khaw, K. T., Johansson, M., Weiderpass, E., Tjønneland, A., Riboli, E., Lathrop, M., Scelo, G., Albanes, D., Caporaso, N. E., Ye, Y., Gu, J., Wu, X., Spitz, M. R., Dienemann, H., Rosenberger, A., Su, L., Matakidou, A., Eisen, T., Stefansson, K., Risch, A., Chanock, S. J., Christiani, D. C., Hung, R. J., Brennan, P., Landi, M. T., Houlston, R. S., & Amos, C. I. (2017). Corrigendum: Rare variants of large effect in BRCA2 and CHEK2 affect risk of lung cancer. Nature genetics, 49(4), 651. https://doi.org/10.1038/ng0417-651a
Wang, Yufei, et al. "Corrigendum: Rare variants of large effect in BRCA2 and CHEK2 affect risk of lung cancer." Nature genetics vol. 49,4 (2017): 651. doi: https://doi.org/10.1038/ng0417-651a
Wang Y, McKay JD, Rafnar T, Wang Z, Timofeeva MN, Broderick P, Zong X, Laplana M, Wei Y, Han Y, Lloyd A, Delahaye-Sourdeix M, Chubb D, Gaborieau V, Wheeler W, Chatterjee N, Thorleifsson G, Sulem P, Liu G, Kaaks R, Henrion M, Kinnersley B, Vallée M, Le Calvez-Kelm F, Stevens VL, Gapstur SM, Chen WV, Zaridze D, Szeszenia-Dabrowska N, Lissowska J, Rudnai P, Fabianova E, Mates D, Bencko V, Foretova L, Janout V, Krokan HE, Gabrielsen ME, Skorpen F, Vatten L, Njølstad I, Chen C, Goodman G, Benhamou S, Vooder T, Välk K, Nelis M, Metspalu A, Lener M, Lubiński J, Johansson M, Vineis P, Agudo A, Clavel-Chapelon F, Bueno-de-Mesquita HB, Trichopoulos D, Khaw KT, Johansson M, Weiderpass E, Tjønneland A, Riboli E, Lathrop M, Scelo G, Albanes D, Caporaso NE, Ye Y, Gu J, Wu X, Spitz MR, Dienemann H, Rosenberger A, Su L, Matakidou A, Eisen T, Stefansson K, Risch A, Chanock SJ, Christiani DC, Hung RJ, Brennan P, Landi MT, Houlston RS, Amos CI. Corrigendum: Rare variants of large effect in BRCA2 and CHEK2 affect risk of lung cancer. Nat Genet. 2017 Mar 30;49(4):651. doi: 10.1038/ng0417-651a. PMID: 28358128.
Copy Download .nbib Format: NLM
Xenobiotic metabolizing gene variants and renal cell cancer: a multicenter study.

Frontiers in oncology

Heck JE, Moore LE, Lee YC, McKay JD, Hung RJ, Karami S, Gaborieau V, Szeszenia-Dabrowska N, Zaridze DG, Mukeriya A, Mates D, Foretova L, Janout V, Kollárová H, Bencko V, Rothman N, Brennan P, Chow WH, Boffetta P.
PMID: 22645715
Front Oncol. 2012 Feb 20;2:16. doi: 10.3389/fonc.2012.00016. eCollection 2012.

BACKGROUND: The countries of Central and Eastern Europe have among the highest worldwide rates of renal cell cancer (RCC). Few studies have examined whether genetic variation in xenobiotic metabolic pathway genes may modify risk for this cancer.METHODS: The Central...

Cite
Heck JE, Moore LE, Lee YC, et al. Xenobiotic metabolizing gene variants and renal cell cancer: a multicenter study. Front Oncol. 2012;2:16doi: 10.3389/fonc.2012.00016.
Heck, J. E., Moore, L. E., Lee, Y. C., McKay, J. D., Hung, R. J., Karami, S., Gaborieau, V., Szeszenia-Dabrowska, N., Zaridze, D. G., Mukeriya, A., Mates, D., Foretova, L., Janout, V., Kollárová, H., Bencko, V., Rothman, N., Brennan, P., Chow, W. H., & Boffetta, P. (2012). Xenobiotic metabolizing gene variants and renal cell cancer: a multicenter study. Frontiers in oncology, 216. https://doi.org/10.3389/fonc.2012.00016
Heck, Julia E, et al. "Xenobiotic metabolizing gene variants and renal cell cancer: a multicenter study." Frontiers in oncology vol. 2 (2012): 16. doi: https://doi.org/10.3389/fonc.2012.00016
Heck JE, Moore LE, Lee YC, McKay JD, Hung RJ, Karami S, Gaborieau V, Szeszenia-Dabrowska N, Zaridze DG, Mukeriya A, Mates D, Foretova L, Janout V, Kollárová H, Bencko V, Rothman N, Brennan P, Chow WH, Boffetta P. Xenobiotic metabolizing gene variants and renal cell cancer: a multicenter study. Front Oncol. 2012 Feb 20;2:16. doi: 10.3389/fonc.2012.00016. eCollection 2012. PMID: 22645715; PMCID: PMC3355831.
Copy Download .nbib Format: NLM
The Utilization of Recycled Masonry Aggregate and Recycled EPS for Concrete Blocks for Mortarless Masonry.

Materials (Basel, Switzerland)

Pavlu T, Fortova K, Divis J, Hajek P.
PMID: 31207927
Materials (Basel). 2019 Jun 14;12(12). doi: 10.3390/ma12121923.

The main aim of this paper is to carry out the environmentally based enhancement of a concrete mixture containing recycled materials whilst considering natural resource consumption as well as mechanical and thermal property levels. The developed concrete is intended...

Cite
Pavlu T, Fortova K, Divis J, et al. The Utilization of Recycled Masonry Aggregate and Recycled EPS for Concrete Blocks for Mortarless Masonry. Materials (Basel). 2019;12(12)doi: 10.3390/ma12121923.
Pavlu, T., Fortova, K., Divis, J., & Hajek, P. (2019). The Utilization of Recycled Masonry Aggregate and Recycled EPS for Concrete Blocks for Mortarless Masonry. Materials (Basel, Switzerland), 12(12), . https://doi.org/10.3390/ma12121923
Pavlu, Tereza, et al. "The Utilization of Recycled Masonry Aggregate and Recycled EPS for Concrete Blocks for Mortarless Masonry." Materials (Basel, Switzerland) vol. 12,12 (2019). doi: https://doi.org/10.3390/ma12121923
Pavlu T, Fortova K, Divis J, Hajek P. The Utilization of Recycled Masonry Aggregate and Recycled EPS for Concrete Blocks for Mortarless Masonry. Materials (Basel). 2019 Jun 14;12(12). doi: 10.3390/ma12121923. PMID: 31207927; PMCID: PMC6630574.
Copy Download .nbib Format: NLM
Correction to: Risk-reducing salpingo-oophorectomy, natural menopause, and breast cancer risk: an international prospective cohort of BRCA1 and BRCA2 mutation carriers.

Breast cancer research : BCR

Mavaddat N, Antoniou AC, Mooij TM, Hooning MJ, Heemskerk-Gerritsen BA, Noguès C, Gauthier-Villars M, Caron O, Gesta P, Pujol P, Lortholary A, Barrowdale D, Frost D, Evans DG, Izatt L, Adlard J, Eeles R, Brewer C, Tischkowitz M, Henderson A, Cook J, Eccles D, van Engelen K, Mourits MJE, Ausems MGEM, Koppert LB, Hopper JL, John EM, Chung WK, Andrulis IL, Daly MB, Buys SS, Benitez J, Caldes T, Jakubowska A, Simard J, Singer CF, Tan Y, Olah E, Navratilova M, Foretova L, Gerdes AM, Roos-Blom MJ, Van Leeuwen FE, Arver B, Olsson H, Schmutzler RK, Engel C, Kast K, Phillips KA, Terry MB, Milne RL, Goldgar DE, Rookus MA, Andrieu N, Easton DF.
PMID: 32102695
Breast Cancer Res. 2020 Feb 26;22(1):25. doi: 10.1186/s13058-020-01259-w.

After publication of the original article [1], we were notified that columns in Table 2 were erroneously displayed.

Cite
Mavaddat N, Antoniou AC, Mooij TM, et al. Correction to: Risk-reducing salpingo-oophorectomy, natural menopause, and breast cancer risk: an international prospective cohort of BRCA1 and BRCA2 mutation carriers. Breast Cancer Res. 2020;22(1):25doi: 10.1186/s13058-020-01259-w.
Mavaddat, N., Antoniou, A. C., Mooij, T. M., Hooning, M. J., Heemskerk-Gerritsen, B. A., Noguès, C., Gauthier-Villars, M., Caron, O., Gesta, P., Pujol, P., Lortholary, A., Barrowdale, D., Frost, D., Evans, D. G., Izatt, L., Adlard, J., Eeles, R., Brewer, C., Tischkowitz, M., Henderson, A., Cook, J., Eccles, D., van Engelen, K., Mourits, M. J. E., Ausems, M. G. E. M., Koppert, L. B., Hopper, J. L., John, E. M., Chung, W. K., Andrulis, I. L., Daly, M. B., Buys, S. S., Benitez, J., Caldes, T., Jakubowska, A., Simard, J., Singer, C. F., Tan, Y., Olah, E., Navratilova, M., Foretova, L., Gerdes, A. M., Roos-Blom, M. J., Van Leeuwen, F. E., Arver, B., Olsson, H., Schmutzler, R. K., Engel, C., Kast, K., Phillips, K. A., Terry, M. B., Milne, R. L., Goldgar, D. E., Rookus, M. A., Andrieu, N., Easton, D. F. (2020). Correction to: Risk-reducing salpingo-oophorectomy, natural menopause, and breast cancer risk: an international prospective cohort of BRCA1 and BRCA2 mutation carriers. Breast cancer research : BCR, 22(1), 25. https://doi.org/10.1186/s13058-020-01259-w
Mavaddat, Nasim, et al. "Correction to: Risk-reducing salpingo-oophorectomy, natural menopause, and breast cancer risk: an international prospective cohort of BRCA1 and BRCA2 mutation carriers." Breast cancer research : BCR vol. 22,1 (2020): 25. doi: https://doi.org/10.1186/s13058-020-01259-w
Mavaddat N, Antoniou AC, Mooij TM, Hooning MJ, Heemskerk-Gerritsen BA, Noguès C, Gauthier-Villars M, Caron O, Gesta P, Pujol P, Lortholary A, Barrowdale D, Frost D, Evans DG, Izatt L, Adlard J, Eeles R, Brewer C, Tischkowitz M, Henderson A, Cook J, Eccles D, van Engelen K, Mourits MJE, Ausems MGEM, Koppert LB, Hopper JL, John EM, Chung WK, Andrulis IL, Daly MB, Buys SS, Benitez J, Caldes T, Jakubowska A, Simard J, Singer CF, Tan Y, Olah E, Navratilova M, Foretova L, Gerdes AM, Roos-Blom MJ, Van Leeuwen FE, Arver B, Olsson H, Schmutzler RK, Engel C, Kast K, Phillips KA, Terry MB, Milne RL, Goldgar DE, Rookus MA, Andrieu N, Easton DF. Correction to: Risk-reducing salpingo-oophorectomy, natural menopause, and breast cancer risk: an international prospective cohort of BRCA1 and BRCA2 mutation carriers. Breast Cancer Res. 2020 Feb 26;22(1):25. doi: 10.1186/s13058-020-01259-w. PMID: 32102695; PMCID: PMC7045606.
Copy Download .nbib Format: NLM
Multigene Panel Germline Testing of 1333 Czech Patients with Ovarian Cancer.

Cancers

Lhotova K, Stolarova L, Zemankova P, Vocka M, Janatova M, Borecka M, Cerna M, Jelinkova S, Kral J, Volkova Z, Urbanova M, Kleiblova P, Machackova E, Foretova L, Hazova J, Vasickova P, Lhota F, Koudova M, Cerna L, Tavandzis S, Indrakova J, Hruskova L, Kosarova M, Vrtel R, Stranecky V, Kmoch S, Zikan M, Macurek L, Kleibl Z, Soukupova J.
PMID: 32295079
Cancers (Basel). 2020 Apr 13;12(4). doi: 10.3390/cancers12040956.

Ovarian cancer (OC) is the deadliest gynecologic malignancy with a substantial proportion of hereditary cases and a frequent association with breast cancer (BC). Genetic testing facilitates treatment and preventive strategies reducing OC mortality in mutation carriers. However, the prevalence...

Cite
Lhotova K, Stolarova L, Zemankova P, et al. Multigene Panel Germline Testing of 1333 Czech Patients with Ovarian Cancer. Cancers (Basel). 2020;12(4)doi: 10.3390/cancers12040956.
Lhotova, K., Stolarova, L., Zemankova, P., Vocka, M., Janatova, M., Borecka, M., Cerna, M., Jelinkova, S., Kral, J., Volkova, Z., Urbanova, M., Kleiblova, P., Machackova, E., Foretova, L., Hazova, J., Vasickova, P., Lhota, F., Koudova, M., Cerna, L., Tavandzis, S., Indrakova, J., Hruskova, L., Kosarova, M., Vrtel, R., Stranecky, V., Kmoch, S., Zikan, M., Macurek, L., Kleibl, Z., & Soukupova, J. (2020). Multigene Panel Germline Testing of 1333 Czech Patients with Ovarian Cancer. Cancers, 12(4), . https://doi.org/10.3390/cancers12040956
Lhotova, Klara, et al. "Multigene Panel Germline Testing of 1333 Czech Patients with Ovarian Cancer." Cancers vol. 12,4 (2020). doi: https://doi.org/10.3390/cancers12040956
Lhotova K, Stolarova L, Zemankova P, Vocka M, Janatova M, Borecka M, Cerna M, Jelinkova S, Kral J, Volkova Z, Urbanova M, Kleiblova P, Machackova E, Foretova L, Hazova J, Vasickova P, Lhota F, Koudova M, Cerna L, Tavandzis S, Indrakova J, Hruskova L, Kosarova M, Vrtel R, Stranecky V, Kmoch S, Zikan M, Macurek L, Kleibl Z, Soukupova J. Multigene Panel Germline Testing of 1333 Czech Patients with Ovarian Cancer. Cancers (Basel). 2020 Apr 13;12(4). doi: 10.3390/cancers12040956. PMID: 32295079; PMCID: PMC7226062.
Copy Download .nbib Format: NLM
Needlestack: an ultra-sensitive variant caller for multi-sample next generation sequencing data.

NAR genomics and bioinformatics

Delhomme TM, Avogbe PH, Gabriel AAG, Alcala N, Leblay N, Voegele C, Vallée M, Chopard P, Chabrier A, Abedi-Ardekani B, Gaborieau V, Holcatova I, Janout V, Foretová L, Milosavljevic S, Zaridze D, Mukeriya A, Brambilla E, Brennan P, Scelo G, Fernandez-Cuesta L, Byrnes G, Calvez-Kelm FL, McKay JD, Foll M.
PMID: 32363341
NAR Genom Bioinform. 2020 Jun;2(2):lqaa021. doi: 10.1093/nargab/lqaa021. Epub 2020 Apr 20.

The emergence of next-generation sequencing (NGS) has revolutionized the way of reaching a genome sequence, with the promise of potentially providing a comprehensive characterization of DNA variations. Nevertheless, detecting somatic mutations is still a difficult problem, in particular when...

Cite
Delhomme TM, Avogbe PH, Gabriel AAG, et al. Needlestack: an ultra-sensitive variant caller for multi-sample next generation sequencing data. NAR Genom Bioinform. 2020;2(2):lqaa021doi: 10.1093/nargab/lqaa021.
Delhomme, T. M., Avogbe, P. H., Gabriel, A. A. G., Alcala, N., Leblay, N., Voegele, C., Vallée, M., Chopard, P., Chabrier, A., Abedi-Ardekani, B., Gaborieau, V., Holcatova, I., Janout, V., Foretová, L., Milosavljevic, S., Zaridze, D., Mukeriya, A., Brambilla, E., Brennan, P., Scelo, G., Fernandez-Cuesta, L., Byrnes, G., Calvez-Kelm, F. L., McKay, J. D., & Foll, M. (2020). Needlestack: an ultra-sensitive variant caller for multi-sample next generation sequencing data. NAR genomics and bioinformatics, 2(2), lqaa021. https://doi.org/10.1093/nargab/lqaa021
Delhomme, Tiffany M, et al. "Needlestack: an ultra-sensitive variant caller for multi-sample next generation sequencing data." NAR genomics and bioinformatics vol. 2,2 (2020): lqaa021. doi: https://doi.org/10.1093/nargab/lqaa021
Delhomme TM, Avogbe PH, Gabriel AAG, Alcala N, Leblay N, Voegele C, Vallée M, Chopard P, Chabrier A, Abedi-Ardekani B, Gaborieau V, Holcatova I, Janout V, Foretová L, Milosavljevic S, Zaridze D, Mukeriya A, Brambilla E, Brennan P, Scelo G, Fernandez-Cuesta L, Byrnes G, Calvez-Kelm FL, McKay JD, Foll M. Needlestack: an ultra-sensitive variant caller for multi-sample next generation sequencing data. NAR Genom Bioinform. 2020 Jun;2(2):lqaa021. doi: 10.1093/nargab/lqaa021. Epub 2020 Apr 20. PMID: 32363341; PMCID: PMC7182099.
Copy Download .nbib Format: NLM
A closer look into close packing: pentacoordinated silicon in a high-pressure polymorph of danburite.

IUCrJ

Pakhomova A, Bykova E, Bykov M, Glazyrin K, Gasharova B, Liermann HP, Mezouar M, Gorelova L, Krivovichev S, Dubrovinsky L.
PMID: 28989722
IUCrJ. 2017 Aug 10;4:671-677. doi: 10.1107/S2052252517010612. eCollection 2017 Sep 01.

Due to their high technological and geological relevance, silicates are one of the most studied classes of inorganic compounds. Under ambient conditions, the silicon in silicates is almost exclusively coordinated by four oxygen atoms, while high-pressure treatment normally results...

Cite
Pakhomova A, Bykova E, Bykov M, et al. A closer look into close packing: pentacoordinated silicon in a high-pressure polymorph of danburite. IUCrJ. 2017;4:671-677doi: 10.1107/S2052252517010612.
Pakhomova, A., Bykova, E., Bykov, M., Glazyrin, K., Gasharova, B., Liermann, H. P., Mezouar, M., Gorelova, L., Krivovichev, S., & Dubrovinsky, L. (2017). A closer look into close packing: pentacoordinated silicon in a high-pressure polymorph of danburite. IUCrJ, 4671-677. https://doi.org/10.1107/S2052252517010612
Pakhomova, Anna, et al. "A closer look into close packing: pentacoordinated silicon in a high-pressure polymorph of danburite." IUCrJ vol. 4 (2017): 671-677. doi: https://doi.org/10.1107/S2052252517010612
Pakhomova A, Bykova E, Bykov M, Glazyrin K, Gasharova B, Liermann HP, Mezouar M, Gorelova L, Krivovichev S, Dubrovinsky L. A closer look into close packing: pentacoordinated silicon in a high-pressure polymorph of danburite. IUCrJ. 2017 Aug 10;4:671-677. doi: 10.1107/S2052252517010612. eCollection 2017 Sep 01. PMID: 28989722; PMCID: PMC5619858.
Copy Download .nbib Format: NLM
Genetic and preventive services for hereditary breast and ovarian cancer in the czech republic.

Hereditary cancer in clinical practice

Foretova L, Petrakova K, Palacova M, Kalabova R, Navratilova M, Lukesova M, Vasickova P, Machackova E, Kleibl Z, Pohlreich P.
PMID: 20222996
Hered Cancer Clin Pract. 2006 Nov 15;4(1):3-6. doi: 10.1186/1897-4287-4-1-3.

The majority of hereditary breast and ovarian cancers can be accounted for by germline mutations in the BRCA1 and BRCA2 genes. Genetic counselling and testing in high-risk patients in the Czech Republic began in 1997 in two centres (Masaryk...

Cite
Foretova L, Petrakova K, Palacova M, et al. Genetic and preventive services for hereditary breast and ovarian cancer in the czech republic. Hered Cancer Clin Pract. 2006;4(1):3-6doi: 10.1186/1897-4287-4-1-3.
Foretova, L., Petrakova, K., Palacova, M., Kalabova, R., Navratilova, M., Lukesova, M., Vasickova, P., Machackova, E., Kleibl, Z., & Pohlreich, P. (2006). Genetic and preventive services for hereditary breast and ovarian cancer in the czech republic. Hereditary cancer in clinical practice, 4(1), 3-6. https://doi.org/10.1186/1897-4287-4-1-3
Foretova, Lenka, et al. "Genetic and preventive services for hereditary breast and ovarian cancer in the czech republic." Hereditary cancer in clinical practice vol. 4,1 (2006): 3-6. doi: https://doi.org/10.1186/1897-4287-4-1-3
Foretova L, Petrakova K, Palacova M, Kalabova R, Navratilova M, Lukesova M, Vasickova P, Machackova E, Kleibl Z, Pohlreich P. Genetic and preventive services for hereditary breast and ovarian cancer in the czech republic. Hered Cancer Clin Pract. 2006 Nov 15;4(1):3-6. doi: 10.1186/1897-4287-4-1-3. PMID: 20222996; PMCID: PMC3401918.
Copy Download .nbib Format: NLM
Identification of Germline Mutations in Melanoma Patients with Early Onset, Double Primary Tumors, or Family Cancer History by NGS Analysis of 217 Genes.

Biomedicines

Stolarova L, Jelinkova S, Storchova R, Machackova E, Zemankova P, Vocka M, Kodet O, Kral J, Cerna M, Volkova Z, Janatova M, Soukupova J, Stranecky V, Dundr P, Foretova L, Macurek L, Kleiblova P, Kleibl Z.
PMID: 33050356
Biomedicines. 2020 Oct 09;8(10). doi: 10.3390/biomedicines8100404.

Cutaneous melanoma is the deadliest skin malignity with a rising prevalence worldwide. Patients carrying germline mutations in melanoma-susceptibility genes face an increased risk of melanoma and other cancers. To assess the spectrum of germline variants, we analyzed 264 Czech...

Cite
Stolarova L, Jelinkova S, Storchova R, et al. Identification of Germline Mutations in Melanoma Patients with Early Onset, Double Primary Tumors, or Family Cancer History by NGS Analysis of 217 Genes. Biomedicines. 2020;8(10)doi: 10.3390/biomedicines8100404.
Stolarova, L., Jelinkova, S., Storchova, R., Machackova, E., Zemankova, P., Vocka, M., Kodet, O., Kral, J., Cerna, M., Volkova, Z., Janatova, M., Soukupova, J., Stranecky, V., Dundr, P., Foretova, L., Macurek, L., Kleiblova, P., & Kleibl, Z. (2020). Identification of Germline Mutations in Melanoma Patients with Early Onset, Double Primary Tumors, or Family Cancer History by NGS Analysis of 217 Genes. Biomedicines, 8(10), . https://doi.org/10.3390/biomedicines8100404
Stolarova, Lenka, et al. "Identification of Germline Mutations in Melanoma Patients with Early Onset, Double Primary Tumors, or Family Cancer History by NGS Analysis of 217 Genes." Biomedicines vol. 8,10 (2020). doi: https://doi.org/10.3390/biomedicines8100404
Stolarova L, Jelinkova S, Storchova R, Machackova E, Zemankova P, Vocka M, Kodet O, Kral J, Cerna M, Volkova Z, Janatova M, Soukupova J, Stranecky V, Dundr P, Foretova L, Macurek L, Kleiblova P, Kleibl Z. Identification of Germline Mutations in Melanoma Patients with Early Onset, Double Primary Tumors, or Family Cancer History by NGS Analysis of 217 Genes. Biomedicines. 2020 Oct 09;8(10). doi: 10.3390/biomedicines8100404. PMID: 33050356; PMCID: PMC7601281.
Copy Download .nbib Format: NLM
Neoadjuvant Chemotherapy of Triple-Negative Breast Cancer: Evaluation of Early Clinical Response, Pathological Complete Response Rates, and Addition of Platinum Salts Benefit Based on Real-World Evidence.

Cancers

Holanek M, Selingerova I, Bilek O, Kazda T, Fabian P, Foretova L, Zvarikova M, Obermannova R, Kolouskova I, Coufal O, Petrakova K, Svoboda M, Poprach A.
PMID: 33808149
Cancers (Basel). 2021 Mar 30;13(7). doi: 10.3390/cancers13071586.

Pathological complete response (pCR) achievement is undoubtedly the essential goal of neoadjuvant therapy for breast cancer, directly affecting survival endpoints. This retrospective study of 237 triple-negative breast cancer (TNBC) patients with a median follow-up of 36 months evaluated the...

Cite
Holanek M, Selingerova I, Bilek O, et al. Neoadjuvant Chemotherapy of Triple-Negative Breast Cancer: Evaluation of Early Clinical Response, Pathological Complete Response Rates, and Addition of Platinum Salts Benefit Based on Real-World Evidence. Cancers (Basel). 2021;13(7)doi: 10.3390/cancers13071586.
Holanek, M., Selingerova, I., Bilek, O., Kazda, T., Fabian, P., Foretova, L., Zvarikova, M., Obermannova, R., Kolouskova, I., Coufal, O., Petrakova, K., Svoboda, M., & Poprach, A. (2021). Neoadjuvant Chemotherapy of Triple-Negative Breast Cancer: Evaluation of Early Clinical Response, Pathological Complete Response Rates, and Addition of Platinum Salts Benefit Based on Real-World Evidence. Cancers, 13(7), . https://doi.org/10.3390/cancers13071586
Holanek, Milos, et al. "Neoadjuvant Chemotherapy of Triple-Negative Breast Cancer: Evaluation of Early Clinical Response, Pathological Complete Response Rates, and Addition of Platinum Salts Benefit Based on Real-World Evidence." Cancers vol. 13,7 (2021). doi: https://doi.org/10.3390/cancers13071586
Holanek M, Selingerova I, Bilek O, Kazda T, Fabian P, Foretova L, Zvarikova M, Obermannova R, Kolouskova I, Coufal O, Petrakova K, Svoboda M, Poprach A. Neoadjuvant Chemotherapy of Triple-Negative Breast Cancer: Evaluation of Early Clinical Response, Pathological Complete Response Rates, and Addition of Platinum Salts Benefit Based on Real-World Evidence. Cancers (Basel). 2021 Mar 30;13(7). doi: 10.3390/cancers13071586. PMID: 33808149; PMCID: PMC8036281.
Copy Download .nbib Format: NLM
Postoperative adrenal insufficiency in Conn's syndrome-does it occur frequently?.

Journal of human hypertension

Zelinka T, Petrák O, Waldauf P, Zítek M, Holaj R, Forejtová L, Michalský D, Novák K, Dušková J, Springer D, Widimský J.
PMID: 34615973
J Hum Hypertens. 2021 Oct 06; doi: 10.1038/s41371-021-00618-0. Epub 2021 Oct 06.

Primary aldosteronism (PA) is the most frequent form of endocrine hypertension. Recently, frequent clinically significant adrenal insufficiency after adrenalectomy in subjects with PA has been reported, which may make the early postsurgical management difficult. We retrospectively searched for possible...

Cite
Zelinka T, Petrák O, Waldauf P, et al. Postoperative adrenal insufficiency in Conn's syndrome-does it occur frequently?. J Hum Hypertens. 2021;doi: 10.1038/s41371-021-00618-0.
Zelinka, T., Petrák, O., Waldauf, P., Zítek, M., Holaj, R., Forejtová, L., Michalský, D., Novák, K., Dušková, J., Springer, D., & Widimský, J. (2021). Postoperative adrenal insufficiency in Conn's syndrome-does it occur frequently?. Journal of human hypertension, . https://doi.org/10.1038/s41371-021-00618-0
Zelinka, Tomáš, et al. "Postoperative adrenal insufficiency in Conn's syndrome-does it occur frequently?." Journal of human hypertension vol. (2021). doi: https://doi.org/10.1038/s41371-021-00618-0
Zelinka T, Petrák O, Waldauf P, Zítek M, Holaj R, Forejtová L, Michalský D, Novák K, Dušková J, Springer D, Widimský J. Postoperative adrenal insufficiency in Conn's syndrome-does it occur frequently?. J Hum Hypertens. 2021 Oct 06; doi: 10.1038/s41371-021-00618-0. Epub 2021 Oct 06. PMID: 34615973.
Copy Download .nbib Format: NLM
Perioperative changes of FGF23 in patients undergoing surgery for primary hyperparathyroidism.

Endocrine connections

Fortova M, Hanouskova L, Valkus M, Cepova J, Prusa R, Kotaska K.
PMID: 34860179
Endocr Connect. 2021 Dec 01; doi: 10.1530/EC-21-0430. Epub 2021 Dec 01.

BACKGROUND: Fibroblast growth factor-23 (FGF23) is a key regulator of urine phosphate excretion. The aim of the study was to investigate the perioperative (intraoperative and postoperative) changes of plasma intact and C-terminal FGF23 (iFGF23, cFGF23) concentrations in patients with...

Cite
Fortova M, Hanouskova L, Valkus M, et al. Perioperative changes of FGF23 in patients undergoing surgery for primary hyperparathyroidism. Endocr Connect. 2021;doi: 10.1530/EC-21-0430.
Fortova, M., Hanouskova, L., Valkus, M., Cepova, J., Prusa, R., & Kotaska, K. (2021). Perioperative changes of FGF23 in patients undergoing surgery for primary hyperparathyroidism. Endocrine connections, . https://doi.org/10.1530/EC-21-0430
Fortova, Magdalena, et al. "Perioperative changes of FGF23 in patients undergoing surgery for primary hyperparathyroidism." Endocrine connections vol. (2021). doi: https://doi.org/10.1530/EC-21-0430
Fortova M, Hanouskova L, Valkus M, Cepova J, Prusa R, Kotaska K. Perioperative changes of FGF23 in patients undergoing surgery for primary hyperparathyroidism. Endocr Connect. 2021 Dec 01; doi: 10.1530/EC-21-0430. Epub 2021 Dec 01. PMID: 34860179.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 33 entries